Abstract
Summary
The global OTC and DTC Infectious Disease Diagnostic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key OTC and DTC Infectious Disease Diagnostic players cover Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
LPI (LP Information)' newest research report, the “OTC and DTC Infectious Disease Diagnostic Industry Forecast” looks at past sales and reviews total world OTC and DTC Infectious Disease Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected OTC and DTC Infectious Disease Diagnostic sales for 2023 through 2029. With OTC and DTC Infectious Disease Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC and DTC Infectious Disease Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global OTC and DTC Infectious Disease Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC and DTC Infectious Disease Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC and DTC Infectious Disease Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC and DTC Infectious Disease Diagnostic and breaks down the forecast by technology, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC and DTC Infectious Disease Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC and DTC Infectious Disease Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by technology
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Segmentation by application
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic, Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
Binx Health Inc.
bioMérieux, Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A
United States market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for OTC and DTC Infectious Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key OTC and DTC Infectious Disease Diagnostic players cover Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
LPI (LP Information)' newest research report, the “OTC and DTC Infectious Disease Diagnostic Industry Forecast” looks at past sales and reviews total world OTC and DTC Infectious Disease Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected OTC and DTC Infectious Disease Diagnostic sales for 2023 through 2029. With OTC and DTC Infectious Disease Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC and DTC Infectious Disease Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global OTC and DTC Infectious Disease Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC and DTC Infectious Disease Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC and DTC Infectious Disease Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC and DTC Infectious Disease Diagnostic and breaks down the forecast by technology, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC and DTC Infectious Disease Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC and DTC Infectious Disease Diagnostic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by technology
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Segmentation by application
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic, Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
Binx Health Inc.
bioMérieux, Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC and DTC Infectious Disease Diagnostic Market Size 2018-2029
2.1.2 OTC and DTC Infectious Disease Diagnostic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 OTC and DTC Infectious Disease Diagnostic Segment by Technology
2.2.1 PCR
2.2.2 Immunodiagnostics
2.2.3 Clinical Microbiology
2.2.4 INAAT
2.2.5 DNA Sequencing and NGS
2.2.6 DNA Microarrays
2.2.7 Others
2.3 OTC and DTC Infectious Disease Diagnostic Market Size by Technology
2.3.1 OTC and DTC Infectious Disease Diagnostic Market Size CAGR by Technology (2018 VS 2022 VS 2029)
2.3.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Technology (2018-2023)
2.4 OTC and DTC Infectious Disease Diagnostic Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals and Clinics
2.4.3 Academic Research Institutes
2.4.4 Others
2.5 OTC and DTC Infectious Disease Diagnostic Market Size by Application
2.5.1 OTC and DTC Infectious Disease Diagnostic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Application (2018-2023)
3 OTC and DTC Infectious Disease Diagnostic Market Size by Player
3.1 OTC and DTC Infectious Disease Diagnostic Market Size Market Share by Players
3.1.1 Global OTC and DTC Infectious Disease Diagnostic Revenue by Players (2018-2023)
3.1.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global OTC and DTC Infectious Disease Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC and DTC Infectious Disease Diagnostic by Regions
4.1 OTC and DTC Infectious Disease Diagnostic Market Size by Regions (2018-2023)
4.2 Americas OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023)
4.3 APAC OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023)
4.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023)
4.5 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size Growth (2018-2023)
5 Americas
5.1 Americas OTC and DTC Infectious Disease Diagnostic Market Size by Country (2018-2023)
5.2 Americas OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023)
5.3 Americas OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC and DTC Infectious Disease Diagnostic Market Size by Region (2018-2023)
6.2 APAC OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023)
6.3 APAC OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC and DTC Infectious Disease Diagnostic by Country (2018-2023)
7.2 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023)
7.3 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC and DTC Infectious Disease Diagnostic by Region (2018-2023)
8.2 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Technology (2018-2023)
8.3 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC and DTC Infectious Disease Diagnostic Market Forecast
10.1 Global OTC and DTC Infectious Disease Diagnostic Forecast by Regions (2024-2029)
10.1.1 Global OTC and DTC Infectious Disease Diagnostic Forecast by Regions (2024-2029)
10.1.2 Americas OTC and DTC Infectious Disease Diagnostic Forecast
10.1.3 APAC OTC and DTC Infectious Disease Diagnostic Forecast
10.1.4 Europe OTC and DTC Infectious Disease Diagnostic Forecast
10.1.5 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Forecast
10.2 Americas OTC and DTC Infectious Disease Diagnostic Forecast by Country (2024-2029)
10.2.1 United States OTC and DTC Infectious Disease Diagnostic Market Forecast
10.2.2 Canada OTC and DTC Infectious Disease Diagnostic Market Forecast
10.2.3 Mexico OTC and DTC Infectious Disease Diagnostic Market Forecast
10.2.4 Brazil OTC and DTC Infectious Disease Diagnostic Market Forecast
10.3 APAC OTC and DTC Infectious Disease Diagnostic Forecast by Region (2024-2029)
10.3.1 China OTC and DTC Infectious Disease Diagnostic Market Forecast
10.3.2 Japan OTC and DTC Infectious Disease Diagnostic Market Forecast
10.3.3 Korea OTC and DTC Infectious Disease Diagnostic Market Forecast
10.3.4 Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Forecast
10.3.5 India OTC and DTC Infectious Disease Diagnostic Market Forecast
10.3.6 Australia OTC and DTC Infectious Disease Diagnostic Market Forecast
10.4 Europe OTC and DTC Infectious Disease Diagnostic Forecast by Country (2024-2029)
10.4.1 Germany OTC and DTC Infectious Disease Diagnostic Market Forecast
10.4.2 France OTC and DTC Infectious Disease Diagnostic Market Forecast
10.4.3 UK OTC and DTC Infectious Disease Diagnostic Market Forecast
10.4.4 Italy OTC and DTC Infectious Disease Diagnostic Market Forecast
10.4.5 Russia OTC and DTC Infectious Disease Diagnostic Market Forecast
10.5 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Forecast by Region (2024-2029)
10.5.1 Egypt OTC and DTC Infectious Disease Diagnostic Market Forecast
10.5.2 South Africa OTC and DTC Infectious Disease Diagnostic Market Forecast
10.5.3 Israel OTC and DTC Infectious Disease Diagnostic Market Forecast
10.5.4 Turkey OTC and DTC Infectious Disease Diagnostic Market Forecast
10.5.5 GCC Countries OTC and DTC Infectious Disease Diagnostic Market Forecast
10.6 Global OTC and DTC Infectious Disease Diagnostic Forecast by Technology (2024-2029)
10.7 Global OTC and DTC Infectious Disease Diagnostic Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott OTC and DTC Infectious Disease Diagnostic Product Offered
11.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Bio-Rad Laboratories Inc
11.2.1 Bio-Rad Laboratories Inc Company Information
11.2.2 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product Offered
11.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bio-Rad Laboratories Inc Main Business Overview
11.2.5 Bio-Rad Laboratories Inc Latest Developments
11.3 BD
11.3.1 BD Company Information
11.3.2 BD OTC and DTC Infectious Disease Diagnostic Product Offered
11.3.3 BD OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 BD Main Business Overview
11.3.5 BD Latest Developments
11.4 Bosch Healthcare Solutions GmbH
11.4.1 Bosch Healthcare Solutions GmbH Company Information
11.4.2 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product Offered
11.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bosch Healthcare Solutions GmbH Main Business Overview
11.4.5 Bosch Healthcare Solutions GmbH Latest Developments
11.5 Danaher
11.5.1 Danaher Company Information
11.5.2 Danaher OTC and DTC Infectious Disease Diagnostic Product Offered
11.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Danaher Main Business Overview
11.5.5 Danaher Latest Developments
11.6 ThermoFisher Scientific
11.6.1 ThermoFisher Scientific Company Information
11.6.2 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product Offered
11.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 ThermoFisher Scientific Main Business Overview
11.6.5 ThermoFisher Scientific Latest Developments
11.7 Siemens AG
11.7.1 Siemens AG Company Information
11.7.2 Siemens AG OTC and DTC Infectious Disease Diagnostic Product Offered
11.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Siemens AG Main Business Overview
11.7.5 Siemens AG Latest Developments
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Information
11.8.2 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product Offered
11.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Holding AG Main Business Overview
11.8.5 Roche Holding AG Latest Developments
11.9 Hologic, Inc.
11.9.1 Hologic, Inc. Company Information
11.9.2 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product Offered
11.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Hologic, Inc. Main Business Overview
11.9.5 Hologic, Inc. Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen OTC and DTC Infectious Disease Diagnostic Product Offered
11.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
11.11 Cardinal Health
11.11.1 Cardinal Health Company Information
11.11.2 Cardinal Health OTC and DTC Infectious Disease Diagnostic Product Offered
11.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Cardinal Health Main Business Overview
11.11.5 Cardinal Health Latest Developments
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Information
11.12.2 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product Offered
11.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Quest Diagnostics Incorporated Main Business Overview
11.12.5 Quest Diagnostics Incorporated Latest Developments
11.13 Ador Diagnostics
11.13.1 Ador Diagnostics Company Information
11.13.2 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product Offered
11.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Ador Diagnostics Main Business Overview
11.13.5 Ador Diagnostics Latest Developments
11.14 Akonni Biosystems, Inc.
11.14.1 Akonni Biosystems, Inc. Company Information
11.14.2 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product Offered
11.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Akonni Biosystems, Inc. Main Business Overview
11.14.5 Akonni Biosystems, Inc. Latest Developments
11.15 Alveo Technologies
11.15.1 Alveo Technologies Company Information
11.15.2 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product Offered
11.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Alveo Technologies Main Business Overview
11.15.5 Alveo Technologies Latest Developments
11.16 Binx Health Inc.
11.16.1 Binx Health Inc. Company Information
11.16.2 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product Offered
11.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Binx Health Inc. Main Business Overview
11.16.5 Binx Health Inc. Latest Developments
11.17 bioMérieux, Inc.
11.17.1 bioMérieux, Inc. Company Information
11.17.2 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Product Offered
11.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 bioMérieux, Inc. Main Business Overview
11.17.5 bioMérieux, Inc. Latest Developments
11.18 Curetis
11.18.1 Curetis Company Information
11.18.2 Curetis OTC and DTC Infectious Disease Diagnostic Product Offered
11.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Curetis Main Business Overview
11.18.5 Curetis Latest Developments
11.19 Sysmex Europe GmbH
11.19.1 Sysmex Europe GmbH Company Information
11.19.2 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product Offered
11.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Sysmex Europe GmbH Main Business Overview
11.19.5 Sysmex Europe GmbH Latest Developments
11.20 Diasorin S.p.A
11.20.1 Diasorin S.p.A Company Information
11.20.2 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product Offered
11.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Diasorin S.p.A Main Business Overview
11.20.5 Diasorin S.p.A Latest Developments
12 Research Findings and Conclusion